Company Overview of Cantata Laboratories, Inc.
Cantata Laboratories, Inc. provides biochemical profiling to clinical diagnostics and drug development. It analyzes the relative concentrations of small molecules using mass spectrometry. The subset of those small molecules that change in an informative way is a biochemical signature for a given disease or drug effect to diagnose the presence of disease, its progression, and evaluate human response to therapy. The company markets its drug biomarker and toxicity signature services to the life sciences industry. Cantata Laboratories was formerly known as Cantata Pharmaceuticals, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
300 Technology Square
Cambridge, MA 02139
Founded in 2002
Key Executives for Cantata Laboratories, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Cantata Laboratories, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.